healthcare
Quadrant-owned Virtus Health targets IPO in 2013
Quadrant Private Equity is targeting a A$500 million ($520 million) IPO this year for its portfolio company Virtus Health, Australia's largest fertility business.
Actis adds to Southeast Asia team
Actis has expanded its Southeast Asia team by appointing Ivy Santoso as Indonesian country head and Arjun Oberoi as global healthcare sector head.
Apollo Hospitals founder interested in Apax stake
Apax Partners is preparing to exit Indian healthcare chain Apollo Hospitals, with Prathap C. Reddy, the company’s founder and chairman, open to buying part of the stake.
Australia's Anacacia in healthcare MBO
Anacacia Capital has acquired Hills Healthcare Equipment from its Australian Securities Exchange-listed parent Hills Holdings through a management buyout. The value of the transaction was not disclosed.
Sequoia invests $9.3m in Indian eye hospitals
Sequoia Capital has invested INR500 million ($9.3 million) in ASG Eye Hospitals, a Rajastan-based group of specialty eye hospitals. The funding will be used by the company to support expansion into central and northern India.
Norwest invests $11m in India's Perfint Healthcare
Norwest Venture Partners has invested $11 million in Indian medical technology company Perfint Healthcare as part of a Series D round of funding. Norwest previously invested $7.2 million in the Chennai-based company in 2010.
Actis invests in Chinese medical equipment manufacturer
Actis has entered China’s healthcare space by purchasing a significant minority stake in Nanjing Micro-Tech, a manufacturer of specialist medical equipment used in hospitals and surgeries.
India Awards: PE Deal of the Year – CARE Hospitals
Advent International spent four years scouting India’s healthcare market before settling on CARE Hospitals, and the transaction itself was complex. Now operating partners are on the ground supporting expansion.
Essex Woodlands promotes Barry, Yang in Shanghai
Silicon Valley-based healthcare investor Essex Woodlands has promoted David Yang and Scott Barry, who run its Shanghai office, to managing director. The promotions, two of five made by the company globally, came into effect on January 1.
Carlyle exits Japan's Qualicaps to Mitsubishi Chemical
The Carlyle Group has exited its holding in Qualicaps, a supplier of pharma-grade capsules, to Mitsubishi Chemical Holdings for JPY55.8billion ($639 million).
ShangPhama board agrees to TPG-backed buyout
ShangPharma Corporation, a Chinese pharmaceutical and biotech research outsourcing firm listed on the New York Stock Exchange, has agreed to management buyout by Michael Hui, the firm’s chairman and CEO, and TPG Capital. The transaction values the company...
Wilson Sonsini opens Beijing office
Venture capital-focused law firm Wilson Sonsini has opened an office in Beijing, enlarging a Greater China footprint that already takes in Shanghai and Hong Kong. The office is led by Kefei Li, a partner with the firm. He reports to Weiheng Chen, the...
Healthcare-focused Essex Woodlands opens Shanghai office
Essex Woodlands, the Silicon Valley-based healthcare investor, has opened an office in Shanghai as it looks to deepen its exposure to one of China’s fastest-growing sectors. David Yang and Scott Barry, both managing directors with the firm, will run operations...
Olympus-backed DM Healthcare targets IPO by 2015
Olympus Capital-backed DM Healthcare, a Dubai-based healthcare services provider which gets a majority of its business in the Middle East, aims to go public by 2015.
Sutherland Global Services to acquire Apollo's PE-backed BPO arm
Sutherland Global Services, a US-based business process and technology management services, has signed a definitive agreement to acquire Apollo Health Street (AHS), Apollo Hospitals’ healthcare business process outsourcing (BPO) arm. The company is part-owned...
Norwest Venture Partners invests $6m in Indian IT firm Attune
Norwest Venture Partners has invested INR326 million ($6 million) in cloud-based IT product company Attune.
Piramal's IndiaVenture Adviors to raise $185m fund
IndiaVenture Advisors, the PE arm of Indian pharmaceuticals company Piramal Enterprises, plans to raise a fund of up to INR10 billion ($185 million) that will target healthcare and education.
Australia's Harbart Private Equity buys Cardioscan
Harbert Australia Private Equity has bought an 85% stake in Melbourne-based cardiac testing service provider Cardioscan.
Abraaj exits Thai hospital with 3x return
Of the 19 million tourists who visited Thailand in 2011, an estimated 500,000 traveled specifically for medical care. Although medical tourism only accounts for 0.4% of national GDP, the industry is growing at an annual rate of 16% and is expected to...
Aureos, GSB exit Thai hospital interest to Malaysia's KPJ
Aureos Capital and GSB Private Funds – a vehicle set up by Thailand’s Government Savings Bank and managed by ING – have agreed to exit their holdings in Vejthani Hospital to KPJ Healthcare, a hospital chain with assets in Malaysia and Indonesia for THB605.6...
IFC invests $25m in Quadria Capital's healthcare fund
International Finance Corporation (IFC), the private investment arm of the World Bank, is planning to invest $25 million into Quadria Capital’s $300 million private equity fund. The vehicle focuses primarily on healthcare sector assets across South and...
TriReme Medical closes $18m round led by Luminor Capital
Singapore-based Luminor Capital has a led a $18 million financing round in TriReme Medica, a medical device company based in Pleasanton, California and Singapore. Major existing investors and new Asian investors also participated.
Matrix India invests in Mewar Orthopaedic
Matrix Partners India has taken a minority stake in specialty healthcare provider Mewar Orthopaedic Hospitals for an undisclosed amount as part of a Series A round of investment.
VCs channel $25m into China's Innovent Biologics
Innovent Biologics, a China-based manufacturer of monoclonal antibodies, has raised $25 million in Series B financing from Lilly Asia Ventures, the VC arm of global pharmaceutical company Eli Lilly, and existing investors Fidelity Biosciences and Fidelity...